Nishan de Silva

2012

In 2012, Nishan de Silva earned a total compensation of $1.3M as VP, Finance and Strategy and Chief Financial Officer at Ligand Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$98,508
Option Awards$803,223
Salary$246,269
Stock Awards$144,700
Other$39,067
Total$1,331,767

de Silva received $803.2K in option awards, accounting for 60% of the total pay in 2012.

de Silva also received $98.5K in non-equity incentive plan, $246.3K in salary, $144.7K in stock awards and $39.1K in other compensation.

Rankings

In 2012, Nishan de Silva's compensation ranked 5,007th out of 11,487 executives tracked by ExecPay. In other words, de Silva earned more than 56.4% of executives.

ClassificationRankingPercentile
All
5,007
out of 11,487
56th
Division
Manufacturing
1,753
out of 4,253
59th
Major group
Chemicals And Allied Products
418
out of 1,203
65th
Industry group
Drugs
270
out of 925
71st
Industry
Pharmaceutical Preparations
212
out of 700
70th
Source: SEC filing on March 12, 2015.

de Silva's colleagues

We found four more compensation records of executives who worked with Nishan de Silva at Ligand Pharmaceuticals in 2012.

2012

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

2012

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2012

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

2012

Charles Berkman

Ligand Pharmaceuticals

General Counsel

In-depth

You may also like